Collectively, these findings indicated that asiatic acid effectively suppresses EGFR activation in both A549 and H1975 NSCLC cells, highlighting its potential as a novel TKI targeting both wild-type and mutant forms of EGFR. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.